|
|
|
Insider
Information: |
Kingsley Alfred D |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
5,968,356 |
|
Indirect Shares
|
1,512,809 |
|
|
Direct
Value |
$5,137,134 |
|
|
Indirect Value
|
$1,323,637 |
|
|
Total
Shares |
7,481,165 |
|
|
Total
Value |
$6,460,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
-3.0
|
3.0
|
Percentage
Gain/Loss : |
-38.5%
|
148.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-22 |
5,470,245 |
2021-06-22 |
1,418,697 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-06-09 |
9,000 |
2015-06-25 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
489,111 |
2023-06-23 |
94,112 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2012-07-30 |
4 |
D |
$4.77 |
$667,254 |
D/D |
(140,000) |
7,512,394 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2010-12-01 |
5 |
A |
$0.00 |
$0 |
D/D |
100,000 |
7,502,394 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2010-11-01 |
4 |
OE |
$2.00 |
$2,074,116 |
D/D |
1,037,058 |
7,402,394 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2012-10-25 |
5 |
A |
$0.00 |
$0 |
D/D |
180,000 |
7,290,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2012-11-15 |
4 |
S |
$2.90 |
$1,000,001 |
D/D |
(344,828) |
7,167,566 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2012-12-14 |
4 |
D |
$4.34 |
$249,414 |
D/D |
(57,511) |
7,110,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2013-03-28 |
4 |
S |
$3.81 |
$762,000 |
D/D |
(200,000) |
7,090,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2013-06-04 |
4 |
S |
$0.00 |
$0 |
D/D |
(320,000) |
6,620,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2013-12-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
32,000 |
6,588,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2010-10-21 |
4 |
OE |
$2.00 |
$894,008 |
D/D |
447,004 |
6,365,336 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2014-05-08 |
4 |
S |
$2.44 |
$730,500 |
D/D |
(300,000) |
6,288,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2014-06-27 |
4 |
OE |
$2.30 |
$115,000 |
D/D |
50,000 |
6,038,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2014-05-16 |
4 |
S |
$2.45 |
$735,000 |
D/D |
(300,000) |
5,988,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2015-11-06 |
4 |
S |
$3.83 |
$383,000 |
D/D |
(100,000) |
5,938,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2010-08-18 |
4 |
OE |
$1.82 |
$1,818,000 |
D/D |
1,000,000 |
5,918,332 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2017-07-31 |
4 |
S |
$2.80 |
$420,000 |
D/D |
(150,000) |
5,781,555 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2016-01-20 |
4 |
S |
$2.35 |
$705,000 |
D/D |
(300,000) |
5,638,055 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
See Remarks |
|
2017-08-17 |
4 |
D |
$2.81 |
$843,000 |
D/D |
(300,000) |
5,481,555 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2021-06-22 |
4 |
OE |
$2.20 |
$135,960 |
D/D |
61,800 |
5,470,245 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,390 |
5,457,945 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2009-12-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,000 |
4,935,432 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2010-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,100 |
4,918,332 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
10% Owner |
|
2009-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,572 |
4,786,765 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
10% Owner |
|
2008-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,671 |
4,778,193 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
10% Owner |
|
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
4,769,522 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|